webinar register page

Topic

RedChip Investor Group Call with Aptorum Group (NASDAQ: APM)

Description

Aptorum Group Limited (Nasdaq: APM) is a clinical stage biopharmaceutical company dedicated to developing and commercializing therapeutic assets to treat diseases with unmet medical needs. Aptorum's current drug pipeline includes indications in oncological diseases (including orphan oncology indications) and infectious diseases. The Company has completed two clinical trials in 2021 in respect of ALS-4 (MRSA) and SACT-1 (Neuroblastoma) small molecule drugs and the Company is currently preparing IND applications for the next phases of human clinical trials in the United States. The Company is preparing to launch a dietary supplement for women undergoing menopause and experiencing related symptoms, including osteoporosis. Targeting a global woman’s health supplement market that is expected to reach $17 billion in 2025, Aptorum is expected to generate near-term revenue with significant long-term growth potential.

Recording Duration

00:41:00

* Required information

Speakers

DARREN LUI

CEO and Executive Director @Aptorum Group Limited

Mr. Darren Lui is the Chief Executive Officer and Executive Director since June 2022. Before that, he was President and an Executive Director of Aptorum Group Limited. Mr. Lui was previously the founder, director and responsible officer of Varengold Capital Securities Limited and Varengold Capital Asset Management Limited in Hong Kong, with subsidiaries operating brokerage, asset management, and investment businesses in Asia established since January 2015. Prior to this, he was a Director within the Fixed Income Group of Barclays Capital, where he spent over nine years from September 2005 to February 2014 developing and establishing their London, Singapore and New York teams. From September 2002 to August 2005 he was qualified as a Chartered Accountant with Ernst & Young LLP (London), specializing in capital markets advisory. Mr. Lui graduated with First-Class Honors from Imperial College, London with a BSc degree in Biochemistry in June 2002. He is a Chartered Accountant (ICAS), accre

Time Zone:

Your Information
Send to
Message preview	Hi there, You are invited to a Zoom webinar. When: Jan 19, 2023 04:15 PM Eastern Time (US and Canada) Topic: RedChip Investor Group Call with Aptorum Group (NASDAQ: APM) Register in advance for this webinar: https://redchip.zoom.us/webinar/register/WN_2FiegJvzSaKtdqXA3s7DUA After registering, you will receive a confirmation email containing information about joining the webinar. ---------- Webinar Speakers DARREN LUI (CEO and Executive Director @Aptorum Group Limited) Mr. Darren Lui is the Chief Executive Officer and Executive Director since June 2022. Before that, he was President and an Executive Director of Aptorum Group Limited. Mr. Lui was previously the founder, director and responsible officer of Varengold Capital Securities Limited and Varengold Capital Asset Management Limited in Hong Kong, with subsidiaries operating brokerage, asset management, and investment businesses in Asia established since January 2015. Prior to this, he was a Director within the Fixed Income Group of Barclays Capital, where he spent over nine years from September 2005 to February 2014 developing and establishing their London, Singapore and New York teams. From September 2002 to August 2005 he was qualified as a Chartered Accountant with Ernst & Young LLP (London), specializing in capital markets advisory. Mr. Lui graduated with First-Class Honors from Imperial College, London with a BSc degree in Biochemistry in June 2002. He is a Chartered Accountant (ICAS), accre

webinar register page

The webinar has ended

Register to watch this recording on-demand

Speakers

webinar register page

The webinar has ended

Register to watch this recording on-demand

Speakers

Share via Email

Switch Time Zone

Upcoming Meetings